{"nctId":"NCT00655057","briefTitle":"Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression","startDateStruct":{"date":"2005-10"},"conditions":["Depression"],"count":66,"armGroups":[{"label":"1","type":"ACTIVE_COMPARATOR","interventionNames":["Procedure: TRODAT-1 single photon emission computed tomographic (SPECT) imaging"]},{"label":"2","type":"EXPERIMENTAL","interventionNames":["Drug: S-citalopram","Procedure: TRODAT-1 single photon emission computed tomographic (SPECT) imaging"]},{"label":"3","type":"ACTIVE_COMPARATOR","interventionNames":["Behavioral: Cognitive behavioral therapy (CBT)","Procedure: TRODAT-1 single photon emission computed tomographic (SPECT) imaging"]}],"interventions":[{"name":"S-citalopram","otherNames":[]},{"name":"Cognitive behavioral therapy (CBT)","otherNames":[]},{"name":"TRODAT-1 single photon emission computed tomographic (SPECT) imaging","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* DSM-IV diagnosis of major depressive episode (MDE) or major depressive disorder (MDD)\n* Drug free of psychotropic medication for more than 6 months before study entry\n* 17-item Hamilton Depression Scale (HAM-D17) score of greater than 16\n* Woman of childbearing age with a negative pregnancy test within 48 hours of study entry\n* Absence of DSM-IV Axis I diagnosis as determined by Structured Clinical Interview for DSM Disorders (SCID)\n\nExclusion Criteria:\n\n* DSM-IV Axis I diagnosis other than MDE\n* History of mania\n* Current alcohol or drug abuse, or alcohol or drug dependence within 6 months before study entry\n* History of sensitivity or intolerance to s-citalopram\n* Medical contraindication to the use of s-citalopram\n* Unstable medical condition (e.g., angina pectoris, untreated hypertension)\n* Pregnant or breastfeeding\n* Woman of childbearing potential not using a medically acceptable form of birth control\n* Actively suicidal or requiring hospitalization\n* Requiring additional psychotropic drug therapy\n* History of transient ischemic attacks\n* History of cerebral infarction (including lacunar infarct with symptoms that last more than 24 hours)\n* History of Binswanger's disease (or a history of hypertensive encephalopathy)\n* History of intracranial hemorrhage\n* History of head trauma with loss of consciousness\n* History of encephalitis\n* History of extended exposure to known neurotoxin (e.g., cyanide, carbon monoxide)\n* Uncontrolled metabolic disorder (e.g., thyroid disease, diabetes mellitus)\n* History of cognitive impairment other than MDE\n* History of normal pressure hydrocephalus\n* History of cancer metastatic to the central nervous system\n* History of Parkinson's disease or other basal ganglia disease\n* History of Guillain-Barre syndrome (chronic or relapsing polyneuropathy)\n* Inability to undergo an MRI scan\n* History of DSM-IV Axis I Mood Disorder","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Dopamine Transporter Binding","description":null,"classes":[]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":0},"commonTop":[]}}}